1.Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9) I# r2 e, b7 I* B @# e9 h http://www.jci.org/articles/view/72992 g+ x% w* x: m, l5 w' o$ A T
2.Reduction in CD4 Central Memory T-cell subset in Co-Stimulation Modulator Abatacept-Treated Patients with Recent-Onset Type 1 Diabetes is Associated with Slower C-Peptide Decline8 a0 |# v+ y- w0 w* b% x% W6 q0 n http://diabetes.diabetesjournals ... /db14-0047.abstract * H' i6 o' n& M9 U ^3.Cdkn2a/p16Ink4a Regulates Fasting-Induced Hepatic Gluconeogenesis Through the PKA-CREB-PGC1α Pathway/ }; A- I- ]+ V& E) b' a. X2 l http://diabetes.diabetesjournals ... /3199.full.pdf+html$ ?- h$ k9 \9 V4 [
4.Cyclin D1 Represses Gluconeogenesis via Inhibition of the Transcriptional Coactivator PGC1α & }3 ^6 D$ E% G B+ N( V3 Ohttp://diabetes.diabetesjournals ... /3266.full.pdf+html ( D1 N1 o) F: t4 Y0 R v# O5.Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline3 L" g+ u% n0 b' X, T http://diabetes.diabetesjournals ... /3449.full.pdf+html